Post

CMS mandates registry data for coverage of Alzheimer’s drugs

The Centers for Medicare and Medicaid Services’ (CMS) Administrator Chiquita Brooks-LaSure announced that Eisai’s Leqembi (lecanemab) will be covered under …

Novartis touts breast cancer win with “landmark” Kisqali results

Kicking off this year's American Society of Clinical Oncology's (ASCO) conference, Novartis has released data supporting the use of its …

Revised EU/Pfizer/BioNTech Covid-19 vaccine deal may lead to a Comirnaty monopoly

The European Commission (EC) and Pfizer/BioNTech have agreed to amend their current supply contract to deliver Covid-19 vaccines to the …

AB Science announces Canadian patent for masitinib to treat ALS

AB Science has secured a Canadian patent for its lead compound masitinib to treat amyotrophic lateral sclerosis (ALS), a fatal …

EC approves Briumvi to treat relapsing forms of multiple sclerosis

The European Commission (EC) has approved TG Therapeutics’ Briumvi (ublituximab-xiiy) to treat relapsing forms of multiple sclerosis (RMS) in adult …